Home | Articles
Published on:March 2020
Indian Journal of Pharmaceutical Education and Research, 2020; 54(2):432-439
Original Article | doi:10.5530/ijper.54.2.49

N-(2-(1H-benzo[d]imidazol-2-yl)Phenyl)-2- (Substituted-styryl)Aniline as Anti-proliferative Agents: Rejuvenating the Importance of Low Molecular Weight Ligands in Oncotherapeutics


Authors and affiliation (s):

Santosh Subhash Chhajed1,*, Pramodkumar P Gupta2, Sanjay Kshirsagar1, Sakshi Tomar1, Debarshi Kar Mahapatra3, Raji Sundararajan4

1Department of Pharmaceutical Chemistry, Institute of Pharmacy, MET’s Bhujbal Knowledge City, Nashik, Maharashtra, INDIA.

2School of Biotechnology and Bioinformatics, D.Y. Patil University, Navi Mumbai, Maharashtra, INDIA.

3Department of Pharmaceutical Chemistry, Dadasaheb Balpande College of Pharmacy, Nagpur, Maharashtra, INDIA.

4School of Engineering Technology, Purdue University, West Lafayette, Indiana, USA.

Abstract:

Background: The rationale behind the study involved that in individuality benzimidazolebased molecules demonstrates significant anti-proliferative activity; chalcone molecules like xanthohumol are known to express noteworthy anti-cancer activity; benzamide derived products show remarkable inhibition of HDAC (an emerging anti-proliferative target) and styrene-based compounds possesses notable anti-tumor activity. Materials and Methods: In this research, an attempt was made to synthesize and characterize a series of hybridized molecules of the prototype (E)-N-(2-(1H-benzo[d]imidazol-2-yl) phenyl)-2-(substituted-styryl)aniline which comprises of a benzimidazole function; along with a chalcone (or styryl) moiety linked by a benzamide. The study involved screening of the novel derivatives against non-small cell lung cancer cell line (H460; ATCC: HTB177) and human colorectal cancer cell line (HCT116; ATCC: CCL-247) using Propidium Iodide assay. In silico docking study was also performed against protein tyrosine kinase (PDB ID: 2J5F) to determine the probable mechanism of action of the novel compounds. Results: The study reflected the profound role and positions of substitution on the phenyl moiety of the benzimidazole system. The compound DSTYR4 displayed most potent antiproliferative activity with IC50 values of 2.98 μM against HCT116 cell line and 5.15 μM against H460 cell line. Conclusion: The research fruitfully rejuvenates the potentials and importance of small molecular weight ligands for experimental oncology.

Key words: Benzimidazole, Benzamide, Styryl, Chalcone, Hybrid, Anti-proliferative.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).

 

Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

User login

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs